UBS Maintains Neutral on Cabot, Lowers Price Target to $92

Benzinga Newsdesk www.benzinga.com Negative 81.9%

Neg 81.9% Neu 0% Pos 0%

UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $97 to $92.

Comments

No comments yet. Be the first!